FDA TGA Approved IPL SHR OPT Device

The spectrum of Intense Pulsed Light Therapy Device is continuous which contains wide  wavelength ranges. It selective light filtering scope is 690/560/420-1200nm. Ascertainable  effects on skin include heat, machine, electromagnetism, photochemistry and physical  stimulation. The working principle of IPL lies in treating benign lesion of skin pigmentation,  vascular disease and hirsutism with IPL’s photothermal effects. Treating results are  realized through different target skin cells’ (including melanin, hemoglobin, collagen, and  water) absorbing ability for photothermy. The combination of short pulse width, low energy density and cooling system guarantee  effective treating results without injuring normal tissues. Based on principle of selective photothermy, i.e. intense pulsed light with wavelength of  690/560/420 ~ 1200nm, which will be penetrated into derma, the abnormal pigment  granules and block mass absorb light and pigments will be resolved. Some resolved  debris will be peeled and remains will be eliminated out of body by phagocyte. After 5-14  days, hyperpigmentation will be lighter and become normal. Treatment principle of Intense Pulsed Light Therapy Device: Multi-wavelengths and colorful wide spectrums produced by Intense Pulsed Light  penetrate into epidermis and reaches dermis. Acting on abnormal pigment cells and target  vascular tissue, IPL dissolves abnormal pigments, closes abnormal vessels, and  stimulates regeneration of collagen. Then, elastic fibers will be rearranged and effects of  pigments removal and skin rejuvenation will be achieved. This treatment is targeted,  symptoms pointed and energy sufficient